Steven Cohen’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
+28,645
New +$379K ﹤0.01% 3252
2025
Q1
Sell
-8,461
Closed -$186K 2101
2024
Q4
$186K Sell
8,461
-89,785
-91% -$1.73M ﹤0.01% 1901
2024
Q3
$1.65M Buy
98,246
+39,946
+69% +$593K ﹤0.01% 1260
2024
Q2
$697K Sell
58,300
-30,200
-34% -$337K ﹤0.01% 1360
2024
Q1
$981K Buy
88,500
+83,200
+1,570% +$849K ﹤0.01% 1466
2023
Q4
$45.9K Buy
+5,300
New +$41.2K ﹤0.01% 2011

Other funds holding CLBT

Steven Cohen's CLBT Position: Q2 2026 in Review

Steven Cohen opened a new position in Cellebrite (CLBT) in Q2 2026: 28,645 shares worth $418K. The stake represents ﹤0.01% of the portfolio and ranks #3252 among its holdings. This is a return to the name: Steven Cohen previously reported a position in CLBT as recently as Q4 2024.

Steven Cohen first reported a position in CLBT in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.65M in Q3 2024. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Steven Cohen held 28,645 shares of Cellebrite worth $418K as of Q2 2026.
  • Cellebrite was a new Steven Cohen position in Q2 2026.
  • Cellebrite made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3252 holding.
  • Steven Cohen first reported a position in Cellebrite in Q4 2023 and has held it in 6 quarters since.
  • Steven Cohen's Cellebrite position peaked at $1.65M in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.